MedEdTalks - Hematology

Vindico Medical Education

0.0 (0)
MEDICINE

MedEdTalks Hematology is an accredited educational podcast for providers to learn more about treating patients with Hematology diseases/disorders. Discover all content and topics by visiting mededtalks.com.

11/25/2020

Harnessing Shared Decision-making in Patients With Hemophilia A With Regina Butler, RN-BC and Courtney Thornburg, MD

In this podcast, expert clinicians review strategies to engage patients with hemophilia A in their own care to improve overall patient satisfaction.

13 min
11/25/2020

Communicating With Patients for Optimized Hemophilia A Care With Regina Butler, RN-BC and Patient Advocate, Charles Felthaus

In this podcast, a clinician and patient discuss his experience with hemophilia A, addressing patient concerns regarding this condition, its management, and preferred communication methods.

14 min
11/25/2020

New Treatment Options to Overcome Challenges in Hemophilia A Management With Regina Butler, RN-BC and Michael Callaghan, MD

In this podcast, expert clinicians discuss recent and emerging treatment options with the potential to benefit patients with and without inhibitors.

14 min
11/25/2020

Historical Challenges Associated With Hemophilia A Management With Regina Butler, RN-BC and Guy Young, MD

In this podcast, expert clinicians discuss historical challenges in hemophilia A care and how recent therapeutic advancements help to overcome these limitations.

15 min
SEASON 1, EPISODE 1 TRAILER

Hemophilia A: Incorporating New Therapeutic Strategies to Address Historical Treatment Challenges

Hemophilia A is an X-linked recessive disease primarily affecting males. An estimated 20,000 individuals in the United States have the disease. Conventional standard of care for patients with severe disease is factor VIII administration given prophylactically or to treat bleeding episodes. Almost 30% of patients treated with factor VIII develop neutralizing antibodies known as inhibitors, which require treatment with expensive bypassing agents. Newer approaches to treating hemophilia A include pegylated recombinant factor VIII agents with a longer half-life that allow for reduced dosing, as well as emicizumab, a bispecific antibody therapy that mimics the cofactor activity of factor VIII by binding to and bridging activated factor IX and factor X. In this 4-part CME podcast series, experts will summarize historical challenges in hemophilia A care; discuss how newer treatment options may benefit patients with and without inhibitors; and present strategies to promote shared decision-making and improve patient satisfaction. Additionally, faculty will speak with a patient advocate regarding treatment concerns and communication preferences.

1 min

TRAILER

Hemophilia A: Incorporating New Therapeutic Strategies to Address Historical Treatment Challenges

Hemophilia A is an X-linked recessive disease primarily affecting males. An estimated 20,000 individuals in the United States have the disease. Conventional standard of care for patients with severe disease is factor VIII administration given prophylactically or to treat bleeding episodes. Almost 30% of patients treated with factor VIII develop neutralizing antibodies known as inhibitors, which require treatment with expensive bypassing agents. Newer approaches to treating hemophilia A include pegylated recombinant factor VIII agents with a longer half-life that allow for reduced dosing, as well as emicizumab, a bispecific antibody therapy that mimics the cofactor activity of factor VIII by binding to and bridging activated factor IX and factor X. In this 4-part CME podcast series, experts will summarize historical challenges in hemophilia A care; discuss how newer treatment options may benefit patients with and without inhibitors; and present strategies to promote shared decision-making and improve patient satisfaction. Additionally, faculty will speak with a patient advocate regarding treatment concerns and communication preferences.

S1, E1

•

1 min

MedEdTalks Hematology is an accredited educational podcast for providers to learn more about treating patients with Hematology diseases/disorders. Discover all content and topics by visiting mededtalks.com.

Creator

Vindico Medical Education
Years Active

2K
Episodes

5
Rating

Clean
Show Website

MedEdTalks - Hematology

MedEdTalks - Hematology

Episodes

Harnessing Shared Decision-making in Patients With Hemophilia A With Regina Butler, RN-BC and Courtney Thornburg, MD

Communicating With Patients for Optimized Hemophilia A Care With Regina Butler, RN-BC and Patient Advocate, Charles Felthaus

New Treatment Options to Overcome Challenges in Hemophilia A Management With Regina Butler, RN-BC and Michael Callaghan, MD

Historical Challenges Associated With Hemophilia A Management With Regina Butler, RN-BC and Guy Young, MD

Hemophilia A: Incorporating New Therapeutic Strategies to Address Historical Treatment Challenges

Trailer

Hemophilia A: Incorporating New Therapeutic Strategies to Address Historical Treatment Challenges

About

Information